XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities:    
Net income (loss) $ (57,600,000) $ (58,800,000)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, Depletion and Amortization 8,828,000 10,584,000
Amortization of Financing Costs and Discounts 1,119,000 5,456,000
Share-based compensation 25,410,000 18,477,000
Provision for doubtful accounts (2,078,000) 5,549,000
Changes in operating assets and liabilities:    
Accounts and unbilled receivables 8,521,000 (8,584,000)
Increase (Decrease) in Deferred Costs 2,296,000 2,343,000
Prepaid expenses and other assets 397,000 131,000
Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 35,000 7,169,000
Accounts payable 593,000 2,175,000
Accrued liabilities (539,000) (11,500,000)
Accrued payroll and other employee benefits 215,000 (10,601,000)
Deferred revenue (4,782,000) (24,240,000)
Net cash provided by (used in) operating activities (17,585,000) (61,841,000)
Investing activities:    
Purchases of property and equipment (2,432,000) (23,551,000)
Payments to Acquire Other Productive Assets 0 (1,265,000)
Payments to Acquire Other Investments (2,670,000) (113,000)
Net cash provided by (used in) investing activities (5,102,000) (24,929,000)
Financing activities:    
Proceeds from Stock Plans 3,111,000 2,824,000
Tax withholding related to net share settlement of restricted stock units (352,000) (20,334,000)
Repayments of Notes Payable (288,000) 0
Proceeds from Convertible Debt 0 146,925,000
Payments of Debt Issuance Costs 0 (675,000)
Purchase of capped call 0 (25,335,000)
Net cash provided by (used in) financing activities 2,471,000 103,405,000
Effect of Exchange Rate on Cash and Cash Equivalents (276,000) (360,000)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect (20,492,000) 16,275,000
Cash and cash equivalents:    
Beginning of period 329,134,000 306,077,000
End of period 308,642,000 322,352,000
Capital Expenditures Incurred but Not yet Paid $ 63,000 $ 3,040,000